Similarly, in a porcine ex vivo intestinal model, CRH induced the release of TNF-α and proteases, through a mast cell-dependent mechanism, thus resulting in augmentation of the intestinal paracellular permeability and mast cell degranulation, which are all hallmarks for IBD and IBS [172,173]. This evidence concerns the gene CRH and inflammatory bowel disease.